ERBB2 and breast carcinoma: In this study, we determined whether a convolutional deep neural network and whole-slide H&E-stained images of The Cancer Genome Atlas (TCGA) breast cancer tumor samples could be used to predict ER signaling pathway activity to determine prognosis in patients with ER + /HER2- breast cancer.